Sermorelin Acetate 10mg Research Peptide
Sermorelin (GHRH 1-29 NH2) is a synthetic peptide corresponding to the first 29 amino acids of endogenous growth hormone-releasing hormone (GHRH), representing the minimal active fragment required for full GHRH receptor activation and GH stimulation. Sermorelin has a well-documented pharmacological profile in the published literature and remains an important reference compound for GHRH receptor research. This 10mg vial provides research-grade Sermorelin Acetate at ≥99% purity, HPLC and MS/MS verified per batch.
Research Background
Sermorelin’s published research history provides a dataset rarely available for GHRH analogues. As the shortest active GHRH fragment, it is used as a reference compound for structure-activity relationship studies examining which GHRH residues are required for receptor binding and GH stimulation. Comparative research with longer analogues including tesamorelin (full 44-amino acid GHRH) and modified GRF 1-29 (CJC-1295 without DAC) uses sermorelin as a baseline for evaluating half-life, receptor affinity, and GH pulse characteristics across the GHRH analogue family.
Compound Specifications
- Format: Lyophilized powder (acetate salt)
- Purity: ≥99% (HPLC verified)
- Quantity: 10mg per vial
- Storage: −20°C, protected from light
- Sequence: GHRH (1-29) NH2
- Molecular Weight: 3357.9 Da
Certificate of Analysis
All Sermorelin Acetate vials are third-party tested by independent ISO-certified laboratories. HPLC and MS/MS validation performed per batch. COA available on request.
For research and laboratory use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.
